ACAD
39.28
+0.06
+0.15%
AEMD
3.776
+0.016
+0.4309%
APRI
3.206
+0.316
+10.9446%
ARNA
1.49
0.00
0.00%
ATEC
2.91
+0.02
+0.69%
CNAT
5.25
+0.03
+0.57%
CRXM
0.255
+0.033
+14.968%
CYTX
1.85
-0.04
-2.12%
DXCM
81.89
+0.5
+0.61%
GNMK
10.545
+0.045
+0.429%
HALO
12.61
+0.05
+0.40%
ILMN
163.37
+2.07
+1.28%
INNV
0.17
+0.01
+6.92%
INO
6.96
-0.04
-0.57%
ISCO
1.04
-0.04
-3.70%
ISIS
57.56
0.00
0.00%
LGND
105.71
+0.38
+0.36%
LPTN
2.93
-0.08
-2.66%
MBVX
3.01
+0.44
+17.12%
MEIP
1.74
+0.02
+1.16%
MNOV
6.11
+0.03
+0.49%
MRTX
6.2
+0.2
+3.33%
MSTX
0.13
+0.001
+0.6966%
NBIX
44.05
+0.9
+2.09%
NUVA
74.22
+0.25
+0.34%
ONCS
1.4
+0.02
+1.45%
ONVO
2.97
+0.08
+2.77%
OREX
4.38
-0.3
-6.41%
OTIC
15.55
+0.5
+3.32%
QDEL
20.89
+0.2
+0.97%
RCPT
231.96
0.00
0.00%
RGLS
1.15
-0.05
-4.17%
RMD
72.27
+0.35
+0.49%
SCIE
0.001
+0.00
+32.00000%
SPHS
2.76
-0.03
-1.08%
SRNE
5.55
-0.07
-1.33%
TROV
2.1
+0.05
+2.44%
VICL
2.26
-0.01
-0.44%
VOLC
18
0.00
0.00%
ZGNX
10.2
-0.25
-2.39%
ACAD
39.28
+0.06
+0.15%
AEMD
3.776
+0.016
+0.4309%
APRI
3.206
+0.316
+10.9446%
ARNA
1.49
0.00
0.00%
ATEC
2.91
+0.02
+0.69%
CNAT
5.25
+0.03
+0.57%
CRXM
0.255
+0.033
+14.968%
CYTX
1.85
-0.04
-2.12%
DXCM
81.89
+0.5
+0.61%
GNMK
10.545
+0.045
+0.429%
HALO
12.61
+0.05
+0.40%
ILMN
163.37
+2.07
+1.28%
INNV
0.17
+0.01
+6.92%
INO
6.96
-0.04
-0.57%
ISCO
1.04
-0.04
-3.70%
ISIS
57.56
0.00
0.00%
LGND
105.71
+0.38
+0.36%
LPTN
2.93
-0.08
-2.66%
MBVX
3.01
+0.44
+17.12%
MEIP
1.74
+0.02
+1.16%
MNOV
6.11
+0.03
+0.49%
MRTX
6.2
+0.2
+3.33%
MSTX
0.13
+0.001
+0.6966%
NBIX
44.05
+0.9
+2.09%
NUVA
74.22
+0.25
+0.34%
ONCS
1.4
+0.02
+1.45%
ONVO
2.97
+0.08
+2.77%
OREX
4.38
-0.3
-6.41%
OTIC
15.55
+0.5
+3.32%
QDEL
20.89
+0.2
+0.97%
RCPT
231.96
0.00
0.00%
RGLS
1.15
-0.05
-4.17%
RMD
72.27
+0.35
+0.49%
SCIE
0.001
+0.00
+32.00000%
SPHS
2.76
-0.03
-1.08%
SRNE
5.55
-0.07
-1.33%
TROV
2.1
+0.05
+2.44%
VICL
2.26
-0.01
-0.44%
VOLC
18
0.00
0.00%
ZGNX
10.2
-0.25
-2.39%
Home » Archive by Category

Xconomy

Organovo to Test Pre-Clinical Drugs on Bio-Printed Kidney Tissue

September 9, 2016 – 9:54 am

It’s been almost two years since Organovo (NYSE: ONVO) created a new business—using its bio-printing technology to create 3-D samples of living human liver tissue for use in testing the…

[[Click headline to continue reading.]]

Bio Roundup: Cancer Wishes and Shopping Lists, Allergan Pricing & More

September 9, 2016 – 3:30 am

[Corrected, 9/12/16, 4:28 p.m. See below.] What do cancer experts want? The moon, perhaps. As part of the Obama administration’s “cancer moonshot” program, a panel of scientists…

[[Click headline to continue reading.]]

Tyler Jacks, Cancer Moonshot Panel Co-Chair, Discusses Roadmap

September 9, 2016 – 3:00 am

The Obama administration wants to speed up cancer research with its “Cancer Moonshot” program—packing 10 years’ worth of work on prevention and treatment programs into five is…

[[Click headline to continue reading.]]

Retrophin Drug Licensed by Shkreli Shows Positive Phase 2 Results

September 7, 2016 – 2:52 pm

Retrophin, the drug developer founded by controversial former biotech executive Martin Shkreli, has posted positive results from a midstage study for its treatment for a rare kidney disease. San…

[[Click headline to continue reading.]]

Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches

September 7, 2016 – 3:30 am

Thanks to remarkable results in a small group of patients, including former U.S. President Jimmy Carter, cancer immunotherapy has spurred talk of once impossible-to-imagine cures and has gained its…

[[Click headline to continue reading.]]

Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More

September 2, 2016 – 3:19 am

A man who helped shed light—fluorescent light—on biology died far too early, at the age of 64. Nobel Prize winner Roger Tsien, a UC San Diego chemist, passed away in Oregon this week. No…

[[Click headline to continue reading.]]

UC San Diego Nobel Laureate Roger Tsien Dies at 64

August 31, 2016 – 9:38 pm

Roger Tsien, a UC San Diego scientist who shared the 2008 Nobel Prize in chemistry for research that led to the development of fluorescent proteins used to illuminate tissue and track biological…

[[Click headline to continue reading.]]

Synthetic Genomics Creates Host Organism Optimized for Bio Industry

August 29, 2016 – 8:00 am

Scientists from Synthetic Genomics, the San Diego-based industrial biotech, have re-engineered a fast-growing microorganism found in salt marsh mud to maximize its production of proteins and to…

[[Click headline to continue reading.]]

The XX Factor: Fixing Biotech’s Gender Imbalance in the C-Suite

August 29, 2016 – 12:00 am

Women continue to be vastly under-represented in management and executive-level positions throughout the life science industry—an inequity that came into the spotlight earlier this year when a…

[[Click headline to continue reading.]]

Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More

August 26, 2016 – 4:55 am

It was the tweet heard around the biotech world, again. Mylan bumped up the price of the EpiPen 400 percent, presidential nominee Hillary Clinton responded with a tirade against drug price hikes,…

[[Click headline to continue reading.]]